Articles

Plant will be CDMO’s first standalone GMP and vaccine development manufacturing site in the country

WuXi Vaccines to Debut New Vaccines Facility in China

Former Novartis plant will become mRNA manufacturing facility, the first in Singapore

Alliance revolves around interoperability of pharma products as they move through the supply chain

Purchase will help CDMO expand into European market 

Manufacturing plant addition features nine new processing suites

New microbial fermentation tech expected to boost CDMO’s overall capacity

Recession warnings impacting the flow of goods and services

Prescription drugs are the main drivers in this effort

Kaysersberg facility’s Lab+ deal expected to bolster CDMO’s filling services

Ten-year digital partnership aims to enhance patient experience 